HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH.

Abstract
Heart hypertrophy is a common finding of acromegaly, a syndrome due to GH excess. Impairment of adenine nucleotide translocase-1 (ANT-1) gene, the main mitochondrial ADP/ATP exchanger, leads to cardiac hypertrophy. The aim of the study was to evaluate cardiac expression and the functional role of ANT-1 in 1- to 12-month-old transgenic mice overexpressing bovine GH (acromegalic mice, Acro) and littermate controls (wild-type mice, Wt). GH specificity of protein degree variation was assessed treating Acro with pegvisomant, a GH receptor competitor. Tissue levels of ANT-1, NF-kappaB, ATP, and lactic acid were evaluated by western blot, bioluminescence, and Fourier transform infrared spectroscopy respectively. The degree of ANT-1 expression was higher in 1-month-old Acro than in Wt (47+/-5% OD vs 33+/-4% OD, P<0 01). On the contrary, ANT-1 expression was lower in 3- to 12-month-old Acro than in Wt (P<0 03). Changes in ANT-1 expression were associated with consistent changes of cellular ATP content, increasing at 1 month (P<0 05) and reducing thereafter in Acro when compared with Wt (P<0 04). Treatment with pegvisomant abolished ANT-1 and ATP changes observed in 1- and 3-month-old Acro, thus supporting a GH-dependent mechanism. Reduced ATP generation in hypertrophied hearts of older Acro was associated with increased lactic acid levels suggesting that part of energy was due to glycolysis. Variations in ANT-1 expression were linked to GH through changes in NF-kappaB, the levels of which changed accordingly. In conclusion, 1-month-old acromegalic mice had increased ANT-1 expression and higher degree of ATP production. Long-standing disease was associated with a consistent reduction of ANT-1 and ATP tissue levels, which became GH-independent in older animals. This study demonstrated a direct effect of GH on key proteins involved in energy metabolism of acromegalic hearts.
AuthorsFausto Bogazzi, Francesco Raggi, Federica Ultimieri, Dania Russo, Antonella Manariti, Aldo D'Alessio, Paolo Viacava, Giovanni Fanelli, Maurizio Gasperi, Luigi Bartalena, Enio Martino
JournalThe Journal of endocrinology (J Endocrinol) Vol. 194 Issue 3 Pg. 521-7 (Sep 2007) ISSN: 0022-0795 [Print] England
PMID17761891 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenine Nucleotide Translocator 1
  • Hormone Antagonists
  • NF-kappa B
  • Receptors, Somatotropin
  • Human Growth Hormone
  • Lactic Acid
  • Adenosine Triphosphate
  • Growth Hormone
  • pegvisomant
Topics
  • Acromegaly (metabolism)
  • Adenine Nucleotide Translocator 1 (analysis, genetics, metabolism)
  • Adenosine Triphosphate (analysis, metabolism)
  • Animals
  • Blotting, Western (methods)
  • Cardiomegaly (metabolism)
  • Cattle
  • Growth Hormone (antagonists & inhibitors, genetics, metabolism)
  • Hormone Antagonists (pharmacology)
  • Human Growth Hormone (analogs & derivatives, pharmacology)
  • Lactic Acid (analysis, metabolism)
  • Mice
  • Mice, Transgenic
  • Models, Animal
  • Myocardium (metabolism)
  • NF-kappa B (analysis, metabolism)
  • Receptors, Somatotropin (antagonists & inhibitors)
  • Spectroscopy, Fourier Transform Infrared
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: